HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

FIBTEM as a predictor of intra- and postoperative blood loss in revision total hip arthroplasty: A prospective observational study.

Abstract
Revision total hip arthroplasty (THA) may cause intra- and postoperative massive bleeding. This prospective observational study evaluated if the maximum clot firmness of FIBTEM (MCFFIB) could act as a predictor of perioperative massive bleeding in revision THA.Fifty-eight adult patients undergoing revision THA were included. Pre- and postoperative MCFFIB, hematological and hemostatic laboratory data, as well as the amount of intra- and postoperative blood loss (IBL and PBL) were obtained.The change rate (MCFFIB-C) between the pre- and postoperative MCFFIB had a significant correlation with IBL (ρ = 0.431, P = .001). Moreover, PBL had a significant correlation with MCFFIB-C (ρ = 0.292, P = .026). The MCFFIB-C cut-off value of ≥ 29% showed the highest sensitivity and specificity for predicting IBL ≥ 1000 mL or PBL ≥500 mL. The incidence of red blood cell transfusion in the postoperative period was higher in patients showing MCFFIB-C ≥ 29% (34% vs 8%, P = .015).The change rate between pre- and postoperative MCFFIB values was correlated well with the amount of IBL or PBL. Moreover, particular change rate of MCFFIB could predict massive bleeding in revision THA.
AuthorsHyun-Jung Shin, Byung-Hun Min, Hyo-Seok Na
JournalMedicine (Medicine (Baltimore)) Vol. 97 Issue 22 Pg. e10929 (Jun 2018) ISSN: 1536-5964 [Electronic] United States
PMID29851830 (Publication Type: Journal Article, Observational Study)
Chemical References
  • Fibrinogen
Topics
  • Aged
  • Arthroplasty, Replacement, Hip (adverse effects, methods)
  • Blood Coagulation Tests (statistics & numerical data)
  • Blood Loss, Surgical (physiopathology)
  • Elasticity
  • Female
  • Fibrinogen (analysis)
  • Humans
  • Male
  • Middle Aged
  • Postoperative Hemorrhage (etiology)
  • Predictive Value of Tests
  • Preoperative Period
  • Prospective Studies
  • Reoperation (adverse effects, methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: